5-amino-1mq nnmt inhibitor study obesity 5-Amino-1MQ is being studied for its relationship with Selective and membrane-permeable small molecule
Description
Age-related NAD+ decline
The Babula 2024 mouse study saw clear fat-mass reduction at 28 days, which scales roughly to 610 weeks in humans
5-Amino-1MQ is commonly studied in research settings for its interaction with metabolic pathways, particularly in relation to NNMT (Nicotinamide N-methyltransferase) activity, cellular energy regulation, and adipose tissue function
Compound class: small-molecule NNMT inhibitor
This lightweight mist delivers copper peptides efficiently to the dermal-epidermal junction, helping support scalp circulation and maintain a healthier follicular environment
